Adam J. Townsend - 10 Feb 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Commercial Officer
Signature
/s/ David Watson, attorney-in-fact for Adam Townsend
Issuer symbol
APLS
Transactions as of
10 Feb 2022
Net transactions value
-$42,172
Form type
4
Filing time
14 Feb 2022, 15:34:23 UTC
Previous filing
01 Feb 2022
Next filing
12 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $42,172 -895 -2% $47.12 44,013 10 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.